Genomic aberrations in renal cell carcinomas detected by restriction landmark genomic scanning

European Journal of Cancer

Volumn 34, Issue 13, 1998, Pages 2112-2118

  Cho, M ^a   Konishi, N ^b   Yamamoto, K ^b   Inui, T ^b   Kitahori, Y ^b   Nakagawa, Y ^a   Uemura, H ^a   Hirao, Y ^a   Hiasa, Y ^b  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

Genome; Renal cell carcinoma; Restriction landmark genomic scanning

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 10; CHROMOSOME 11; CHROMOSOME 17; CHROMOSOME 18; CHROMOSOME 2; CHROMOSOME 3; CHROMOSOME 9; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROPHORESIS; FEMALE; GENE AMPLIFICATION; GENE DELETION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; PRIORITY JOURNAL; RESTRICTION LANDMARK GENOMIC SCANNING;

AGED; BLOTTING, SOUTHERN; CARCINOMA, RENAL CELL; CHROMOSOME ABERRATIONS; DNA, NEOPLASM; FEMALE; HUMANS; KIDNEY NEOPLASMS; LIGASES; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; PROTEINS; RESTRICTION MAPPING; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 17144467935     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00261-5     Document Type: Article

References (38)

1. 1. Kovacs G, Frisch S. Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas. Cancer Res 1989, 49, 651-659.
2. 2. Morita R, Ishikawa J, Tsutsumi M, et al. Allelotype of renal cell carcinoma. Cancer Res 1991, 51, 820-823.
3. 3. Ogawa O, Kakehi Y, Ogawa K, Koshiba M, Sugiyama T, Yoshida O. Allelic loss at chromosome 3p characterizes clear cell phenotype of renal cell carcinoma. Cancer Res 1991, 51, 949-953.
4. 4. Yamakawa K, Morita R, Takahashi E, Hori T, Ishikawa J, Nakamura Y. A detailed deletion mapping of the short arm of chromosome 3 in sporadic renal cell carcinoma. Cancer Res 1991, 51, 4707-4711.
5. 5. Presti JC, Reuter VE, Cordon-Cardo C, Mazumdar M, Fair WR, Jhanwar SC. Allelic deletions in renal tumors: histopathological correlations. Cancer Res 1993, 53, 5780-5783.
6. 6. Foster K, Crossey PA, Hetherington JW, et al. Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22. Br J Cancer 1994, 69, 230-234.
7. 7. Lubinski J, Hadaczek P, Podolski J, et al. Common regions of deletion in chromosome regions 3p12 and 3p14.2 in primary clear cell renal carcinomas. Cancer Res 1994, 54, 3710-3713.
8. 8. Latif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993, 260, 1317-1320.
9. 9. Shuin T, Kondo K, Torigoe S, et al. Frequent somatic mutations and loss of heterozygosity of the Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 1994, 54, 2852-2854.
10. 10. Hatada I, Hayashizaki Y, Hirotsune S, Komatsubara H, Mukai T. A genomic scanning method for higher organisms using restriction sites as landmarks. Proc Natl Acad Sci USA 1991, 88, 9523-9527.
11. 11. Hirotsune S, Hatada I, Komatsubara H, et al. New approach for detection of amplification in cancer DNA using restriction landmark genomic scanning. Cancer Res 1992, 52, 3642-3647.
12. 12. Nagai H, Ponglikitmongkol M, Mita E, et al. Aberration of genomic DNA in association with human hepatocellular carcinomas detected by 2-dimensional gel analysis. Cancer Res 1994, 54, 1545-1550.
13. 13. Kawai J, Hirose K, Fushiki S, et al. Comparison of DNA methylation patterns among mouse cell lines by restriction landmark genomic scanning. Mol Cell Biol 1994, 14, 7421-7427.
14. 14. Yoshikawa H, De La Monte S, Nagai H, Wands JR, Matsubara K, Fujiyama A. Chromosomal assignment of human genomic Not I restriction fragments in a two-dimensional electrophoresis profile. Genomics 1996, 31, 28-35.
15. 15. Konishi N, Hiasa Y, Nakamura M, Kitahori Y, Matsubara K, Nagai H. Different patterns of DNA alterations detected by restriction landmark genomic scanning in heterogeneous prostate carcinomas. Am J Pathol 1997, 150, 305-314.
16. 16. Nakamura M, Konishi N, Tsunoda S, et al. Analyses of human gliomas by restriction landmark genomic scanning. J Neuro-Oncol 1997, 35, 113-120.
17. 17. Konishi N, Hiasa Y, Matsuda H, Nakamura M, Kitahori Y. Genetic variations in human benign prostatic hyperplasia detected by restriction landmark genomic scanning. J Urol 1997, 157, 1499-1503.
18. 18. Mostofi FK, Sesterhen IA, Sobin LH. Histological Typing of Kidney Tumors. International Histological Classification of Tumours no. 25. Geneva, WHO, 1981.
19. 19. UICC. TNM Atlas. Illustrated Guide to the TNM/pTNM Classification of Malignant Tumours, 3rd edition, 2nd revision. Berlin, Springer, 1992.
20. 20. Percy C, Van Holton V, Muir C (eds). International Classification of Diseases for Oncology. Geneva, WHO, 1990.
21. 21. Feinberg AP, Vogelstein BA. Technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1984, 137, 266-267.
22. 22. Yao M, Shuin T, Misaki H, Kubota Y. Enhanced expression of c-myc and epidermal growth factor receptor (C-erb B-1) genes in primary human renal cancer. Cancer Res 1988, 48, 6753-6757.
23. 23. Presti JC Jr, Moch H, Reuter VE, Cordon-Cardo C, Waldman FM. Renal cell carcinoma genetic analysis by comparative genomic hybridization and restriction fragment length polymorphism analysis. J Urol 1996, 156, 281-285.
24. 24. Ogawa O, Habuchi T, Kakehi Y, Koshiba M, Sugiyama T, Yoshida O. Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p. Cancer Res 1992, 52, 1881-1885.
25. 25. Reiter RE, Anglard P, Liu S, Gnarra JR, Linehan WM. Chromosome 17p deletions and p53 mutations in renal cell carcinoma. Cancer Res 1993, 53, 3092-3097.
26. 26. Brooks JD, Bova GS, Marshall FF, Isaacs WB. Tumor suppressor gene allelic loss in human renal cancers. J Urol 1993, 150, 1278-1283.
27. 27. Bird AP. CpG-rich islands and the function of DNA methylation. Nature (London) 1986, 321, 209-213.
28. 28. Lindsay S, Bird AP. Use of restriction enzymes to detect potential gene sequences in mammalian DNA. Nature (London) 1987, 327, 336-338.
29. 29. Jones PA. DNA methylation errors and cancer. Cancer Res 1996, 56, 2463-2467.
30. 30. Sakai T, Toguchida J, Ohtani N, Yandell DW, Rapaport JM, Dryja TP. Allele specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am J Human Genet 1991, 48, 880-888.
31. 31. Costello JF, Berger MS, Huang HS, Cavenee WK. Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation. Cancer Res 1996, 56, 2405-2410.
32. 32. Herman JG, Latif F, Weng Y, et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 1994, 91, 9700-9704.
33. 33. Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T, Hirohashi S. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci USA 1995, 92, 7416-7419.
34. 34. Brewster SF, Gingell JC, Browne S, Brown KW. Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional carcinoma of the bladder. Br J Cancer 1994, 70, 697-700.
35. 35. Frank CJ, McClatchey KD, Devaney KO, Carey TE. Evidence that loss of chromosome 18q is associated with tumor progression. Cancer Res 1997, 57, 824-827.
36. 36. Fearon ER, Cho KR, Nigro JM, et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 1990, 247, 49-56.
37. 37. Uchida T, Wada C, Wang C, Egawa S, Ohtani H, Koshiba K. Genomic instability of microsatellite repeats and mutations of H-, K-, and N-ras, and p53 genes in renal cell carcinoma. Cancer Res 1994, 54, 3682-3685.
38. 38. Nagai H, Tsumura H, Ponglikitmongkol M, Kim Y, Matsubara K. Genomic aberrations in human hepatoblastomas detected by 2-dimensional gel analysis. Cancer Res 1995, 55, 4549-4551.